Fig. 5.
Percent change in pial arteriolar diameter (±SE) during 2 h of MCAO and 20 min of reperfusion with continuous superfusion of vehicle (0.02% DMSO, n = 9) or 3 μM BQ610 starting at 15 min of MCAO followed by no transfusion (n = 8) or ZL-HbBv exchange transfusion (n = 7) at 35 min. Two-way ANOVA indicated a significant interaction between treatment groups and time (P < 0.001); *P < 0.05 from vehicle superfusion by Newman-Keuls multiple range test.